Leelyn Smith LLC acquired a new position in shares of Morgan Stanley (NYSE:MS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,304 shares of the financial services provider’s stock, valued at approximately $764,000.
A number of other institutional investors have also recently added to or reduced their stakes in MS. Junto Capital Management LP acquired a new stake in Morgan Stanley in the 3rd quarter valued at $170,037,000. Marshall Wace LLP grew its stake in Morgan Stanley by 40.2% in the 3rd quarter. Marshall Wace LLP now owns 2,933,604 shares of the financial services provider’s stock valued at $466,326,000 after acquiring an additional 841,263 shares during the period. Ameriprise Financial Inc. grew its stake in Morgan Stanley by 6.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 14,260,650 shares of the financial services provider’s stock valued at $2,267,847,000 after acquiring an additional 822,120 shares during the period. Two Sigma Investments LP grew its stake in Morgan Stanley by 150.3% in the 3rd quarter. Two Sigma Investments LP now owns 1,234,969 shares of the financial services provider’s stock valued at $196,311,000 after acquiring an additional 741,651 shares during the period. Finally, Danske Bank A S acquired a new stake in Morgan Stanley in the 3rd quarter valued at $104,097,000. Institutional investors and hedge funds own 84.19% of the company’s stock.
Insiders Place Their Bets
In other Morgan Stanley news, insider Daniel A. Simkowitz sold 14,690 shares of Morgan Stanley stock in a transaction on Friday, April 17th. The shares were sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the sale, the insider owned 365,802 shares of the company’s stock, valued at $69,224,370.48. The trade was a 3.86% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Eric F. Grossman sold 11,118 shares of Morgan Stanley stock in a transaction on Monday, April 20th. The stock was sold at an average price of $190.75, for a total transaction of $2,120,758.50. Following the sale, the insider directly owned 169,403 shares in the company, valued at approximately $32,313,622.25. This trade represents a 6.16% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 110,444 shares of company stock valued at $20,665,049 in the last 90 days. 0.17% of the stock is owned by insiders.
Morgan Stanley Trading Down 0.8%
Morgan Stanley (NYSE:MS – Get Free Report) last announced its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.02 by $0.41. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.89%. The company had revenue of $20.58 billion for the quarter, compared to analysts’ expectations of $19.23 billion. During the same quarter in the previous year, the company posted $2.60 EPS. The firm’s quarterly revenue was up 16.0% on a year-over-year basis. Research analysts forecast that Morgan Stanley will post 11.8 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 30th will be paid a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, April 30th. Morgan Stanley’s payout ratio is 36.23%.
More Morgan Stanley News
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Major broker price-target raises: Bank of America boosted its MS target to $225 (Buy) citing management messaging and business momentum — an analyst-level endorsement that tends to support buying interest. BofA Lifts PT on Morgan Stanley to $225
- Positive Sentiment: BMO Capital also raised its price target to $220 and kept Outperform — another institutional signal likely to attract demand from research-driven funds. BMO Capital adjusts PT on Morgan Stanley to $220
- Positive Sentiment: Spot Bitcoin ETF flows have surged recently and Morgan Stanley’s MSBT (its spot BTC ETF) has pulled meaningful inflows — positive for MS’s wealth/asset-management fee narrative and AUM growth potential. Spot Bitcoin ETFs Add $996M as Flows Near Record High
- Positive Sentiment: Momentum and media coverage: recent write-ups and weekly performance commentary (MS up vs. peers) can draw ETF and momentum flows into MS stock. That technical interest can amplify analyst-driven moves. MS up 6.29% in One Week
- Neutral Sentiment: Ongoing research activity: Morgan Stanley’s research franchise remains active (new coverage/targets across T‑Mobile, Verizon, AT&T and others). That strengthens the firm’s advisory/research positioning but is a longer-term reputation signal rather than an immediate earnings driver. Morgan Stanley Assumes Coverage of T‑Mobile
- Neutral Sentiment: Analyst chatter about MS strategy and stock picks (e.g., memory/AI calls) highlights the firm’s market role but doesn’t directly change MS earnings—so mixed/neutral near term. 5 Morgan Stanley Stock Picks Leading 2026 Strategy
- Negative Sentiment: Insider selling: MS disclosed an Eric F. Grossman sale of 11,118 shares (~$2.1M) and other insider disposals were reported — aggregated insider sales can weigh on near-term sentiment even if they’re for personal/liquidity reasons. Insider Sale: Eric Grossman
- Negative Sentiment: Additional SEC-filed insider sales reported in media (multi-million dollar disposals) amplify the negative read for some investors and can pressure the stock despite positive analyst notes. Morgan Stanley Insider Sells
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on MS. Evercore lifted their price target on shares of Morgan Stanley from $190.00 to $210.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Barclays lifted their price target on shares of Morgan Stanley from $219.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, April 16th. UBS Group raised shares of Morgan Stanley from a “neutral” rating to a “buy” rating and lifted their price target for the company from $195.00 to $196.00 in a research note on Tuesday, April 7th. Jefferies Financial Group cut shares of Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 9th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Morgan Stanley from $173.00 to $179.00 and gave the company a “neutral” rating in a research note on Tuesday, March 10th. Ten equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $201.33.
View Our Latest Report on Morgan Stanley
Morgan Stanley Profile
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Read More
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
